


AMR-One Health
Antimicrobial resistance (AMR) is a global health security threat. Our AMR response focuses on strengthening public health systems in our region.
Group Heads
About
Antimicrobial resistance (AMR) is a global health security threat, complicating efforts to fight diseases like HIV, malaria and tuberculosis. Microbes that have developed medicine resistance (‘superbugs’) cause drug-resistant infections contributing to nearly 5 million deaths annually. Our AMR response focuses on strengthening public health systems in our region.
Our aim is to improve our region’s response to the growing global health security threat of antimicrobial resistance. We work with governments, national AMR committees and public health counterparts across the region, supporting national AMR action plans and priorities.
Our work contains four key themes.
Infection prevention and control
Through training and mentoring, we establish relevant policies and procedures for monitoring selected healthcare-associated infections.
AMR response
We train and mentor in stewardship for monitoring antibiotic use, managing antimicrobial stewardship and responding to emerging issues.
AMR laboratory capacity and surveillance
We offer training, mentoring and support to:
- improve AMR detection
- undertake surveillance of the World Health Organization’s priority AMR pathogens
- establish efficient referral pathways for AMR pathogens.
One Health approach
We embrace a One Health approach. This recognises that the health of people is closely connected to the health of animals and our shared environment.
We therefore conduct cross-sectoral surveillance of AMR and antimicrobial use across human and animal health.
Current projects

Improving disease outbreak response time in the Pacific: 7-1-7 tool testing
We're working with partners to see how the 7-1-7 approach can help track and respond to disease outbreaks in the Pacific.

Tackling antimicrobial resistance in Papua New Guinea
By 2050, antimicrobial resistant bacteria (AMR) could cause 10 million deaths annually. Our collaborative project supports Papua New Guinea’s domestic AMR response.
Fleming Fund Country Grant: Papua New Guinea
Burnet Institute is leading the Papua New Guinea Country Grant component of the Fleming Fund, a UK Aid program tackling antimicrobial resistance in low- and middle-income countries.
News and features
Group contacts
Group members

Dr Amrita Ronnachit
Senior Technical Advisor

Dr Chloe Story
Technical Advisor
Dr Victor Musyoki
Researcher
Department of Medical Microbiology & Immunology, University of Nairobi

James Lawson
Program Manager / Country Program Manager

Dr Kudakwashe Chani
Head, AMR-One Health Group

Mona Kheng
Surveillance Officer – Antimicrobial Resistance

Dr Nomvuyo Mothobi
Technical Advisor

Possawat Jorakate
Technical Coordinator
